Evidence map›Paper›PMID 25561540›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Targeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndrome.

Meiyu Xu, Andrew Kobets, Jung-Chieh Du, Jessica Lennington, Lina Li, Mounira Banasr, Ronald S Duman, Flora M Vaccarino, Ralph J DiLeone, Christopher Pittenger

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed, 2 pooled it
25.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 2 syntheses or guidelines pooled it, 157 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Tourette syndrome.Nature reviews. Disease primers · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A mismatch between striatal cholinergic pauses and dopaminergic reward prediction errors.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Activation of MBritish journal of pharmacology · 2024
    Article
  13. Review
  14. Article
  15. The role of neuroactive steroids in tic disorders.Neuroscience and biobehavioral reviews · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Meiyu XuDepartments of Psychiatry.
Andrew KobetsDepartments of Psychiatry.
Jung-Chieh DuDepartments of Psychiatry.
Jessica LenningtonChild Study Center and.
Lina LiDepartments of Psychiatry.
Mounira BanasrDepartments of Psychiatry.
Ronald S DumanDepartments of Psychiatry, Pharmacology, Interdepartmental Neuroscience Program, Yale University, New Haven, CT 06519.
Flora M VaccarinoChild Study Center and Interdepartmental Neuroscience Program, Yale University, New Haven, CT 06519 Neurobiology.
Ralph J DiLeoneDepartments of Psychiatry, Interdepartmental Neuroscience Program, Yale University, New Haven, CT 06519 Neurobiology.
Christopher PittengerDepartments of Psychiatry, Child Study Center and Interdepartmental Neuroscience Program, Yale University, New Haven, CT 06519 Psychology, and the christopher.pittenger@yale.edu.
Yale University · USChild Development Center · QA

Funding

Yale University Clinical and Translational Science Award ProgramUL1TR000142 · NCATS · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2012 to 2015
$31.8M
TRAINING PROGRAM IN CHILDHOOD NEUROPSYCHIATRIC DISORDERST32MH018268 · NIMH · YALE UNIVERSITY · PI Michael H Bloch, MICHAEL J CROWLEY · 1985 to 2026
$11.0M
Pathophysiologically Realistic Mouse Models of Neuropsychiatric Disease: TouretteR01MH091861 · NIMH · YALE UNIVERSITY · PI PITTENGER, CHRISTOPHER JOHN · 2010 to 2014
$2.0M
Inhibitory Interneurons in Tourette SyndromeR01NS054994 · NINDS · YALE UNIVERSITY · PI VACCARINO, FLORA M · 2007 to 2010
$1.1M
CREB and the molecular underpinnings of habit learningK08MH081190 · NIMH · YALE UNIVERSITY · PI PITTENGER, CHRISTOPHER JOHN · 2008 to 2012
$897k
NCATS NIH HHS UL1 TR000142NIMH NIH HHS K08 MH081190NIMH NIH HHS K08MH081190NIMH NIH HHS R01 MH091861NIMH NIH HHS R01MH091861NIMH NIH HHS T32 MH018268NIMH NIH HHS T32MH018268NINDS NIH HHS R01 NS054994
6 · The paper itself

Abstract

Gilles de la Tourette syndrome (TS) is characterized by tics, which are transiently worsened by stress, acute administration of dopaminergic drugs, and by subtle deficits in motor coordination and sensorimotor gating. It represents the most severe end of a spectrum of tic disorders that, in aggregate, affect ∼ 5% of the population. Available treatments are frequently inadequate, and the pathophysiology is poorly understood. Postmortem studies have revealed a reduction in specific striatal interneurons, including the large cholinergic interneurons, in severe disease. We tested the hypothesis that this deficit is sufficient to produce aspects of the phenomenology of TS, using a strategy for targeted, specific cell ablation in mice. We achieved ∼ 50% ablation of the cholinergic interneurons of the striatum, recapitulating the deficit observed in patients postmortem, without any effect on GABAergic markers or on parvalbumin-expressing fast-spiking interneurons. Interneuron ablation in the dorsolateral striatum (DLS), corresponding roughly to the human putamen, led to tic-like stereotypies after either acute stress or d-amphetamine challenge; ablation in the dorsomedial striatum, in contrast, did not. DLS interneuron ablation also led to a deficit in coordination on the rotorod, but not to any abnormalities in prepulse inhibition, a measure of sensorimotor gating. These results support the causal sufficiency of cholinergic interneuron deficits in the DLS to produce some, but not all, of the characteristic symptoms of TS.

Indexed as

Action PotentialsAnimalsCholine O-AcetyltransferaseCorpus StriatumDiphtheria ToxinInterneuronsMiceMice, TransgenicPhenotypeReceptors, CholinergicTourette SyndromeCholine O-AcetyltransferaseDiphtheria ToxinReceptors, Cholinergicacetylcholineanimal modelsbasal gangliainterneuronsTourette sydrome

Identifiers

PMID25561540
PMCPMC4311862
OpenAlexW2058693322

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.